Overview

Absentia Labs builds an AI-driven, organism-wide modeling platform that helps biotech and pharmaceutical teams assess drug safety and translational risk early in development. Its core AI-native engine combines biological, chemical, and assay data to simulate how a drug behaves in the body across whole organs, predicting efficacy and safety issues before preclinical tests. By focusing on organ-specific risks like liver, heart, and kidney liabilities, the platform aims to identify problem candidates early and guide which drugs to advance. This approach is designed to reduce late-stage failures and speed up the process of bringing medicines to the clinic, offering a more ethical and cost-effective alternative to traditional animal testing. Absentia Labs positions itself as the intelligence layer for molecular medicine, working with universities and biopharma partners to standardize and accelerate drug discovery and development.